Varenzin™-CA1 (molidustat oral suspension) is the first and only FDA
conditionally approved option for the treatment of non-regenerative
anemia in cats with chronic kidney disease (CKD).

▪Liquid given orally to the cat once daily for up to 28 days; treatment
may be repeated as needed after a minimum seven-day pause
▪Approved for at-home treatment, no in-clinic injections needed
▪For cats 3.4 lb and over
▪Shelf life of 2 years
▪Dosing syringe included
▪Fish oil flavor